[Clinical usefulness of tumor markers associated with pancreatic cancer]
- PMID: 7908065
[Clinical usefulness of tumor markers associated with pancreatic cancer]
Abstract
Most of the recently developed tumor antigens detected by monoclonal antibodies are sugar chains and frequently associated with blood group substance. By immunohistochemical studies, we evaluated mainly the clinical usefulness and significance of the serum assay of CA-50 classified as a type 1 sugar chain, sialyl SSEA-1 as a type 2 sugar chain, and ST-439 with an undetermined structure, as well as their clinicopathological significance. In addition, the value of measurement of CA19-9, ST-439, and SLX in pure pancreatic juice (PPJ) was investigated. Furthermore, the clinical usefulness of K-ras mutation at codon 12 (KRM) in PPJ was studied. The incidence of serum CA19-9 among tumor markers was highest in pancreatic cancer (81%), but relatively high in benign diseases. On the other hand, both serological and immunohistological studies showed that sialyl SSEA-1 and ST-439 were highly specific for the tumor, whereas they appeared in serum or tumor less frequently than CA19-9 or CA-50 carrying the type 1 sugar chain. The accuracy of the tumor markers (CA19-9, sialyl SSEA-1, and ST-439) for pancreatic cancer, was almost equal (77% to 80%) and higher than that of CEA (69%). However, a highly positive correlation between sialyl SSEA-1 and ST-439 was revealed as well as among type 1 sugar chains in malignant diseases. Therefore, we conclude that the combination assay with CA19-9 or a similar tumor marker, sialyl SSEA-1 or ST-439, and CEA would be appropriate for the screening of pancreatic cancer. When the cut off value was set as the M + 2SD of the controls, significantly elevated concentrations of CA19-9 in PPJ were found in the secretory phase in 90% of the patients with pancreatic cancer (PC) and 66% of the patients with chronic pancreatitis (CP). Although increased concentrations of CA19-9 in PPJ have no cancer specificity, measurement of CA19-9 in PPJ can be used as a sensitive marker for some pancreatic disorders. On the other hand, concentrations of ST-439 and SLX in PPJ were significantly increased only in PC, and their incidences were 50% and 40%, respectively. They have a high tumor-specificity, but their incidences were not as high as initially expected.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
[Cancer-associated carbohydrate antigens available for serum diagnosis].Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-1):1091-101. Gan To Kagaku Ryoho. 1988. PMID: 2898921 Review. Japanese.
-
[Clinical evaluation of serum sialyl SSEA-1 (SLX) in diagnosis of cancers].Nihon Shokakibyo Gakkai Zasshi. 1989 May;86(5):1141-8. Nihon Shokakibyo Gakkai Zasshi. 1989. PMID: 2571740 Japanese.
-
Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.Nihon Sanka Fujinka Gakkai Zasshi. 1989 Feb;41(2):217-24. Nihon Sanka Fujinka Gakkai Zasshi. 1989. PMID: 2566639
-
Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay.Pancreas. 1998 Nov;17(4):341-7. doi: 10.1097/00006676-199811000-00004. Pancreas. 1998. PMID: 9821175
-
Role of tumour markers, cytogenetics.Ann Oncol. 1999;10 Suppl 4:145-9. Ann Oncol. 1999. PMID: 10436809 Review.
Cited by
-
Diagnostic value of combining CA 19-9 and K-ras gene mutation in pancreatic carcinoma: a meta-analysis.Int J Clin Exp Med. 2014 Oct 15;7(10):3225-34. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25419353 Free PMC article.
-
Detection of K-ras gene mutations in feces by magnetic nanoprobe in patients with pancreatic cancer: A preliminary study.Exp Ther Med. 2018 Jan;15(1):527-531. doi: 10.3892/etm.2017.5368. Epub 2017 Oct 24. Exp Ther Med. 2018. PMID: 29250161 Free PMC article.
-
Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer.Cancer Biomark. 2011-2012;11(1):1-14. doi: 10.3233/CBM-2012-0260. Cancer Biomark. 2011. PMID: 22820136 Free PMC article.
-
Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. Report of two cases.Int J Pancreatol. 1997 Dec;22(3):227-31. doi: 10.1007/BF02788389. Int J Pancreatol. 1997. PMID: 9444555
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous